Douglas J. Manion

Douglas J. Manion, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Aclaris Therapeutics, Inc. and Arena Pharmaceuticals Inc. The record holds 10 filings, for trades running from 15 August 2021 to 1 January 2024.

The open-market record is one-sided, with 2 purchases worth €94k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 share grants and 2 option exercises.

The record was last updated on 3 January 2024 with a share grant (€8,666) in Aclaris Therapeutics, Inc. The most recent open-market purchase was published on 17 March 2023, 1,317 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.